Bionano Genomics Inc (BNGO)

$1.27 -0.02 (-1.55%)
Market Cap 14.31M
Revenue (ttm) 28.51M
Net Income (ttm) -26.40M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -92.60%
Debt to Equity Ratio 0.00
Volume 177,300
Avg Vol 335,590
Day's Range N/A - N/A
Shares Out 11.09M
Stochastic %K 52%
Beta 1.62
Analysts Strong Sell
Price Target $5.00

Company Profile

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-resu...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 858 888 7600
Website: bionano.com
Address:
9540 Towne Centre Drive, Suite 100, San Diego, United States
flow2me
flow2me May. 11 at 11:05 PM
$BNGO that run to 13 lol 5 years goes by quick
0 · Reply
JinUzuki
JinUzuki May. 11 at 9:15 PM
$BNGO NEW CEO… get ready for a new ALL TIME LOW
0 · Reply
Bizingo
Bizingo May. 11 at 3:29 PM
$BNGO Just a reminder - BNGO raised roughly a third of a billion dollars during the meme-stock era and has since burned through essentially almost all of it while never reaching sustainable profitability. How Holmlin still has a job is amazing.
0 · Reply
Ryanc25d
Ryanc25d May. 11 at 2:07 PM
$BNGO hopefully Eric goes to jail
0 · Reply
JonnyBGood12345
JonnyBGood12345 May. 8 at 11:08 AM
$BNGO new orders will pick this up in the next few months
1 · Reply
WallStreetBuyDip
WallStreetBuyDip May. 8 at 8:29 AM
Especially with small caps like $BNGO, I'm very strict and buy only when H% is low. $BNGO is one ticker I've traded over and over again along with other small/mid cap stocks. Will buy again when H% is low for a reversal trade.
0 · Reply
Discreetsuccess
Discreetsuccess May. 8 at 6:23 AM
$BNGO well, well well.
0 · Reply
v92
v92 May. 8 at 3:39 AM
$BNGO Hi, Erik.
0 · Reply
pilotwave26
pilotwave26 May. 8 at 12:07 AM
$BNGO it’s the best bullish news ever came out, u dumb 🤡
0 · Reply
BartDude1977
BartDude1977 May. 7 at 7:09 PM
$BNGO fuck you, Erik. People don’t forget that you stole their money
1 · Reply
Latest News on BNGO
Bionano Genomics files $400M mixed securities shelf

2026-05-08T23:01:48.000Z - 3 days ago

Bionano Genomics files $400M mixed securities shelf

Bionano Genomics CEO Erik Holmlin to step down, Al Luderer to succeed

2026-05-07T00:20:18.000Z - 5 days ago

Bionano Genomics CEO Erik Holmlin to step down, Al Luderer to succeed

Bionano Announces Leadership Transition

May 6, 2026, 4:30 PM EDT - 5 days ago

Bionano Announces Leadership Transition

Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025

May 5, 2026, 8:00 AM EDT - 6 days ago

Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025

Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026

Apr 29, 2026, 4:05 PM EDT - 12 days ago

Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026

Bionano Genomics price target lowered to $6 from $7 at H.C. Wainwright

2026-04-13T10:18:13.000Z - 4 weeks ago

Bionano Genomics price target lowered to $6 from $7 at H.C. Wainwright

Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma

Apr 2, 2026, 8:00 AM EDT - 5 weeks ago

Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma

Bionano Genomics Earnings Call Transcript: Q4 2025

Mar 23, 2026, 4:30 PM EDT - 7 weeks ago

Bionano Genomics Earnings Call Transcript: Q4 2025

Bionano Genomics reports Q4 revenue $7.95M vs. $8.16M last year

2026-03-23T20:16:27.000Z - 7 weeks ago

Bionano Genomics reports Q4 revenue $7.95M vs. $8.16M last year

Bionano Genomics sees Q1 revenue $6.5M-$6.7M

2026-03-23T20:15:56.000Z - 7 weeks ago

Bionano Genomics sees Q1 revenue $6.5M-$6.7M

Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026

Mar 23, 2026, 4:05 PM EDT - 7 weeks ago

Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026

Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026

Mar 9, 2026, 4:05 PM EDT - 2 months ago

Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026

Bionano Genomics announces Bionano Symposium Day 4 highlights

2026-02-27T13:11:08.000Z - 2 months ago

Bionano Genomics announces Bionano Symposium Day 4 highlights

Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale

Feb 27, 2026, 8:00 AM EST - 2 months ago

Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale

Bionano Genomics announces Bionano Symposium Day 3 highlights

2026-02-26T13:37:50.000Z - 2 months ago

Bionano Genomics announces Bionano Symposium Day 3 highlights

10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM's Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders

Feb 26, 2026, 8:00 AM EST - 2 months ago

10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM's Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders

11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy

Feb 25, 2026, 8:00 AM EST - 2 months ago

11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy

Bionano Genomics announces Bionano Symposium Day 1 highlights

2026-02-24T13:11:39.000Z - 2 months ago

Bionano Genomics announces Bionano Symposium Day 1 highlights

9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies

Feb 24, 2026, 8:00 AM EST - 2 months ago

9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies

Bionano Genomics announces Bionano Symposium 2026

2026-02-09T14:10:50.000Z - 3 months ago

Bionano Genomics announces Bionano Symposium 2026

Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping

Feb 9, 2026, 9:05 AM EST - 3 months ago

Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping

Bionano Genomics announces publication on OGM, gene editing technology

2026-02-04T13:21:16.000Z - 3 months ago

Bionano Genomics announces publication on OGM, gene editing technology

Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies

Feb 4, 2026, 8:00 AM EST - 3 months ago

Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies

Bionano Genomics reports preliminary Q4 revenue $7.8M-$8M

2026-01-12T13:17:13.000Z - 4 months ago

Bionano Genomics reports preliminary Q4 revenue $7.8M-$8M

Bionano Genomics recaps advances in OGM showcased at AMP 2025

2025-12-11T13:26:28.000Z - 5 months ago

Bionano Genomics recaps advances in OGM showcased at AMP 2025

Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies

Dec 3, 2025, 8:00 AM EST - 5 months ago

Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies

Bionano Genomics price target lowered to $7 from $11 at H.C. Wainwright

2025-11-24T11:15:34.000Z - 6 months ago

Bionano Genomics price target lowered to $7 from $11 at H.C. Wainwright

Bionano Genomics Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 6 months ago

Bionano Genomics Earnings Call Transcript: Q3 2025

Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress

Nov 13, 2025, 4:01 PM EST - 6 months ago

Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress

Bionano Genomics announces publication of study on OGM

2025-11-06T13:33:02.000Z - 6 months ago

Bionano Genomics announces publication of study on OGM

Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia

Nov 6, 2025, 8:00 AM EST - 6 months ago

Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia

Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025

Oct 30, 2025, 4:05 PM EDT - 6 months ago

Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025

Bionano Genomics participates in a conference call with H.C. Wainwright

2025-10-15T14:15:47.000Z - 7 months ago

Bionano Genomics participates in a conference call with H.C. Wainwright

Bionano Genomics Transcript: H.C. Wainwright @ Home Event

Oct 15, 2025, 10:00 AM EDT - 7 months ago

Bionano Genomics Transcript: H.C. Wainwright @ Home Event

Bionano to Participate in the H.C. Wainwright @ Home Event

Oct 7, 2025, 8:00 AM EDT - 7 months ago

Bionano to Participate in the H.C. Wainwright @ Home Event

Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering

Sep 17, 2025, 5:00 PM EDT - 8 months ago

Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering

Bionano Genomics prices 5M shares at $2.00 in public offering

2025-09-16T13:15:38.000Z - 8 months ago

Bionano Genomics prices 5M shares at $2.00 in public offering

Bionano Genomics issues book series related to OGM in chromoanagenesis research

2025-09-16T11:10:39.000Z - 8 months ago

Bionano Genomics issues book series related to OGM in chromoanagenesis research

Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology

Sep 16, 2025, 7:00 AM EDT - 8 months ago

Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology

Bionano Genomics announces CMS posted preliminary payment determination for OGM

2025-09-15T11:15:05.000Z - 8 months ago

Bionano Genomics announces CMS posted preliminary payment determination for OGM

CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Genetic Disorders

Sep 15, 2025, 7:00 AM EDT - 8 months ago

CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Genetic Disorders

Bionano Genomics Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 3:00 PM EDT - 8 months ago

Bionano Genomics Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Bionano to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 25, 2025, 8:00 AM EDT - 9 months ago

Bionano to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Bionano Genomics Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 9 months ago

Bionano Genomics Earnings Call Transcript: Q2 2025

Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress

Aug 14, 2025, 4:01 PM EDT - 9 months ago

Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress

Bionano Genomics Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 13, 2025, 3:00 PM EDT - 9 months ago

Bionano Genomics Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL

Aug 7, 2025, 8:00 AM EDT - 9 months ago

Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL

Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference

Aug 6, 2025, 8:00 AM EDT - 9 months ago

Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference

Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025

Jul 31, 2025, 4:05 PM EDT - 10 months ago

Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025

Bionano Genomics Transcript: AGM 2025

Jun 11, 2025, 1:00 PM EDT - 11 months ago

Bionano Genomics Transcript: AGM 2025

Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders

May 19, 2025, 8:00 AM EDT - 1 year ago

Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders

Bionano Genomics Earnings Call Transcript: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings Call Transcript: Q1 2025

Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress

May 14, 2025, 4:01 PM EDT - 1 year ago

Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress

Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies

May 13, 2025, 8:00 AM EDT - 1 year ago

Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies

Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025

May 7, 2025, 4:01 PM EDT - 1 year ago

Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

May 2, 2025, 9:30 AM EDT - 1 year ago

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease

Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM

Bionano Genomics Earnings Call Transcript: Q4 2024

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings Call Transcript: Q4 2024

Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025

Mar 31, 2025, 4:01 PM EDT - 1 year ago

Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025

Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting

Mar 18, 2025, 8:00 AM EDT - 1 year ago

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting

Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025

Mar 14, 2025, 8:00 AM EDT - 1 year ago

Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025

Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML

Mar 13, 2025, 9:00 AM EDT - 1 year ago

Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML

Bionano Announces Effective Date of Reverse Stock Split

Jan 22, 2025, 4:05 PM EST - 1 year ago

Bionano Announces Effective Date of Reverse Stock Split

Bionano Genomics Transcript: EGM 2025

Jan 15, 2025, 1:00 PM EST - 1 year ago

Bionano Genomics Transcript: EGM 2025

Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Jan 6, 2025, 4:30 PM EST - 1 year ago

Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Jan 3, 2025, 2:34 PM EST - 1 year ago

Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway

Dec 31, 2024, 3:26 PM EST - 1 year ago

Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway

Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis

Dec 23, 2024, 8:30 AM EST - 1 year ago

Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis

Bionano Genomics Earnings Call Transcript: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

Bionano Genomics Earnings Call Transcript: Q3 2024

Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress

Nov 13, 2024, 4:01 PM EST - 1 year ago

Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress

Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry

Nov 4, 2024, 4:14 AM EST - 1 year ago

Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry

Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Oct 31, 2024, 4:30 PM EDT - 1 year ago

Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Bionano Adjourns Special Meeting of Stockholders to November 27, 2024

Oct 31, 2024, 8:10 AM EDT - 1 year ago

Bionano Adjourns Special Meeting of Stockholders to November 27, 2024

Bionano Announces Preliminary 3Q 2024 Revenues and Cash

Oct 10, 2024, 8:00 AM EDT - 1 year ago

Bionano Announces Preliminary 3Q 2024 Revenues and Cash

Bionano Genomics Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 9, 2024, 11:00 AM EDT - 1 year ago

Bionano Genomics Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Bionano Genomics Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Aug 13, 2024, 3:30 PM EDT - 1 year ago

Bionano Genomics Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Bionano Genomics Earnings Call Transcript: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 1 year ago

Bionano Genomics Earnings Call Transcript: Q2 2024

Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress

Aug 7, 2024, 4:01 PM EDT - 1 year ago

Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress

Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference

Jul 31, 2024, 4:01 PM EDT - 1 year ago

Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference

Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 8, 2024, 5:25 PM EDT - 2 years ago

Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

flow2me
flow2me May. 11 at 11:05 PM
$BNGO that run to 13 lol 5 years goes by quick
0 · Reply
JinUzuki
JinUzuki May. 11 at 9:15 PM
$BNGO NEW CEO… get ready for a new ALL TIME LOW
0 · Reply
Bizingo
Bizingo May. 11 at 3:29 PM
$BNGO Just a reminder - BNGO raised roughly a third of a billion dollars during the meme-stock era and has since burned through essentially almost all of it while never reaching sustainable profitability. How Holmlin still has a job is amazing.
0 · Reply
Ryanc25d
Ryanc25d May. 11 at 2:07 PM
$BNGO hopefully Eric goes to jail
0 · Reply
JonnyBGood12345
JonnyBGood12345 May. 8 at 11:08 AM
$BNGO new orders will pick this up in the next few months
1 · Reply
WallStreetBuyDip
WallStreetBuyDip May. 8 at 8:29 AM
Especially with small caps like $BNGO, I'm very strict and buy only when H% is low. $BNGO is one ticker I've traded over and over again along with other small/mid cap stocks. Will buy again when H% is low for a reversal trade.
0 · Reply
Discreetsuccess
Discreetsuccess May. 8 at 6:23 AM
$BNGO well, well well.
0 · Reply
v92
v92 May. 8 at 3:39 AM
$BNGO Hi, Erik.
0 · Reply
pilotwave26
pilotwave26 May. 8 at 12:07 AM
$BNGO it’s the best bullish news ever came out, u dumb 🤡
0 · Reply
BartDude1977
BartDude1977 May. 7 at 7:09 PM
$BNGO fuck you, Erik. People don’t forget that you stole their money
1 · Reply
BartDude1977
BartDude1977 May. 7 at 7:09 PM
$BNGO that mf took our money, did basically nothing for 5 years, now the dude is resigning. Dude is worse than Elizabeth Holmes.
2 · Reply
Peaceouty
Peaceouty May. 7 at 6:36 PM
$BNGO Erik resigning is bearish imo. In the end he’s the godfather of the tech with limited use but very inspiring. Good luck out there Erik! Donate our money to charity or something.
1 · Reply
JinUzuki
JinUzuki May. 7 at 4:42 PM
$BNGO heard Erik is gone… I just wanted to take the time to say thank you Erik. Thank you for all the hard work, the massive success and strategic vision you had when it came to fucking over investors in this company. No one could have done it better.
1 · Reply
MisterNessuno
MisterNessuno May. 7 at 3:18 PM
$BNGO Tic Toc Tic Toc , who will it buy this sweet baby
0 · Reply
pilotwave_
pilotwave_ May. 7 at 2:41 PM
$BNGO finally the crook is out
0 · Reply
focafoca99
focafoca99 May. 6 at 9:35 PM
$BNGO assumed interim CEO duties as Al Luderer steps in as president and chief executive officer. https://www.rapidticker.com/news/bngo-bionano-announces-leadership-transition-f79dcd
0 · Reply
focafoca99
focafoca99 May. 6 at 9:26 PM
$BNGO named Albert A. Luderer as interim CEO after terminating President and CEO R. Erik Holmlin. https://www.rapidticker.com/news/bngo-sec-filing-390058
0 · Reply
v92
v92 May. 6 at 9:04 PM
$BNGO This!!!! Other than Eric being a total retard, the only other issue is that their tech is totally worthless. 🤣
0 · Reply
ShowMeThaMonay
ShowMeThaMonay May. 6 at 8:40 PM
$BNGO
0 · Reply
Wdr2558
Wdr2558 May. 6 at 8:38 PM
$BNGO it took that long to replace that useless retard Erik Holmlin??? The entire board needs to get fired!!!
0 · Reply
JumpStarting
JumpStarting May. 6 at 7:42 PM
$FLNA $BNGO $TLRY Let's go!
2 · Reply
BartDude1977
BartDude1977 May. 5 at 2:34 PM
$BNGO this company needs to actually be investigated. What did they do with all of the investors money?
1 · Reply